Projects per year
Fingerprint
Dive into the research topics where Arash Hatefi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 5 Finished
-
Stem Cell-based Platform for Targeted Enzyme/Prodrug Therapy of Recurrent Ovarian Cancer
Hatefi, A. (PI)
4/1/21 → 3/31/24
Project: Research
-
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
Hatefi, A. (PI)
4/1/15 → 3/31/21
Project: Research
-
Bioengineering a Safe and Efficient Vector Technology for Stem Cell Transfection
Hatefi, A. (PI)
5/15/14 → 10/31/17
Project: Research project
-
Development of a Nanotechnology Platform for Prostate Cancer Gene Therapy
Hatefi, A. (PI)
1/1/08 → 12/31/08
Project: Research project
-
Development of a Nature-Inspired Vector for Targeted Systemic Breast Cancer Gene Therapy
Hatefi, A. (PI)
1/1/06 → 12/31/06
Project: Research project
-
A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab’s epitope with versatile biochemical, biological, and medical applications
Nikkhoi, S. K., Heydarzadeh, H., Vandavasi, V. G., Yang, G., Louro, P., Polunas, M., Owji, H. & Hatefi, A., Feb 2024, In: Immunologic Research. 72, 1, p. 103-118 16 p.Research output: Contribution to journal › Article › peer-review
-
A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide
Yang, G., Nikkhoi, S. K., Owji, H., Li, G., Massumi, M., Cervelli, J., Vandavasi, V. G. & Hatefi, A., Sep 2024, In: Antibodies. 13, 3, 75.Research output: Contribution to journal › Article › peer-review
Open Access -
A quantitative MRI-based approach to estimate the permeation and retention of nanomedicines in tumors
Nomani, A., Yousefi, S., Sargsyan, D. & Hatefi, A., Apr 2024, In: Journal of Controlled Release. 368, p. 728-739 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice
Khoshtinat Nikkhoi, S., Yang, G., Owji, H., Grizotte-Lake, M., Cohen, R. I., Gil Gonzalez, L., Massumi, M. & Hatefi, A., Mar 15 2024, In: Journal for ImmunoTherapy of Cancer. 12, 3, e008295.Research output: Contribution to journal › Article › peer-review
Open Access -
Synergistic antitumor effect of liposomal-based formulations of olaparib and topotecan in primary epithelial ovarian cancer cells
Romaniuk-Drapala, A., Skupin-Mrugalska, P., Garbuzenko, O., Hatefi, A. & Minko, T., Dec 2024, In: Cancer Cell International. 24, 1, 285.Research output: Contribution to journal › Article › peer-review
Open Access